✨ Free AI Report
Zomedica Corp.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Zomedica Corp.
Company Research

Zomedica Corp.: Business Overview, Financials & Competitive Analysis

Zomedica Corp. scores 4/10 on the AskCyborg Cyborg Score (Mixed). Early-stage veterinary medtech player with solid product innovation and market traction, but execution risk and capital efficiency concerns remain key watchpoints. Zomedica shows operational progress with double-digit revenue growth, improved cash efficiency (25% reduction in cash burn), and strong gross margins, plus ISO 13485 certification achieved November 2025. However, the.

What is Zomedica Corp.'s industry? Zomedica Corp. (zomedica.com) operates in Veterinary Diagnostics and Therapeutics / Animal Health Medical Devices. AskCyborg classifies Zomedica Corp. under Veterinary Diagnostics and Therapeutics / Animal Health Medical Devices in its company registry.

Zomedica Corp. is a veterinary health company developing diagnostic and therapeutic products for companion animals and equine markets. The company focuses on addressing unmet clinical needs for veterinarians through i...

4/ 10Mixed

Cyborg Score thesis

Early-stage veterinary medtech player with solid product innovation and market traction, but execution risk and capital...

Read the full analyst-debate transcript →
Industry Veterinary Diagnostics and Therapeutics / Animal Health Medical Devices
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Zomedica Corp. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Zomedica Corp.

AskCyborg analysts argue the bull and bear cases for Zomedica Corp. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Zomedica Corp. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Zomedica Corp. Overview

Pro stress-test →

Zomedica Corp. is a veterinary health company developing diagnostic and therapeutic products for companion animals and equine markets. The company focuses on addressing unmet clinical needs for veterinarians through innovative point-of-care diagnostic platforms and therapeutic devices, including its flagship TRUFORMA biosensor, Assisi Loop therapy systems, PulseVet electrohydraulic shockwave therapy, and TRUVIEW digital cytology microscope.

Strategic Profile

Pro stress-test →

Zomedica operates in a growing $2.7+ billion total addressable market in veterinary diagnostics and therapeutics. The company achieved 16% year-over-year revenue growth in Q3 2025 to $8.1M with strong 67% gross margins and maintained a solid $54.4M cash position. International expansion is a key growth driver, with international sales growing 20% and strategic partnerships expanding distribution across Europe and North America.

Competitive Landscape

Pro stress-test →

Zomedica competes in the fragmented veterinary diagnostics and therapeutics market against larger players like Zoetis (diagnostic platforms), regional veterinary pharmaceutical suppliers, and emerging point-of-care device manufacturers. Key competitive advantages include proprietary TRUFORMA biosensor technology, integrated therapeutic platforms (Assisi Loop, PulseVet), and strategic partnerships with distributors expanding international reach.

Industry Context

Zomedica Corp. operates in Veterinary Diagnostics and Therapeutics / Animal Health Medical Devices.

Key facts

Founded: 2013 · Headquarters: Ann Arbor, Michigan, United States · Employees: ~25 · Revenue: $8.1M (Q3 2025, annualized ~$32M)

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Zomedica Corp..

  • Q3 2025 diagnostics revenue surged 51% YoY, demonstrating strong adoption of TRUFORMA platform and expanding diagnostic menu with new assays for equine and feline applications
  • Delisted from NYSE American to OTCQB in March 2025, indicating near-term capital market challenges but operational improvements visible in reduced cash burn (25% improvement YoY) and sequential operating expense reductions
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • November 2025Achieved ISO 13485:2016 certification for manufacturing facilities in Plymouth, Minnesota and Roswell, Georgia
  • November 2025Launched Assisi Loop Lounge tPEMF therapy bed for small animals with lifetime warranty
  • +2 moreTrack every material event for Zomedica Corp. as it happens. Explore monitoring →
Get alerted when Zomedica Corp. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Veterinary Diagnostic PlatformsLarge-cap animal health conglomerate with extensive diagnostic and pharmaceutical offerings→Veterinary TherapeuticsVeterinary pharmaceutical and therapeutic product manufacturer→Veterinary Practice Software/DevicesStrategic partner and competitor for veterinary practice technology solutions→

Compare Zomedica Corp. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Zomedica Corp. operates in Veterinary Diagnostics and Therapeutics / Animal Health Medical Devices. See how the rest of the sector scores on the Cyborg framework.

Browse Veterinary Diagnostics and Therapeutics / Animal Health Medical Devices research →
NEW · MCP server

Ask your AI assistant about Zomedica Corp.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Zomedica Corp. and its top competitor on Cyborg Score”
“What did Zomedica Corp. do this quarter?”
“Is Zomedica Corp. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Zomedica Corp. do?+
Zomedica Corp. is a veterinary health company developing diagnostic and therapeutic products for companion animals and equine markets. The company focuses on addressing unmet clinical needs for veterinarians through i...
What is Zomedica Corp.'s Cyborg Score?+
Zomedica Corp. has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Zomedica Corp.'s main competitors?+
Named competitors include Veterinary Diagnostic Platforms, Veterinary Therapeutics, Veterinary Practice Software/Devices. The full competitive landscape is in the AskCyborg report.
How can I get the full Zomedica Corp. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Zomedica Corp. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Zomedica Corp. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.